Table 1.
Method* | In vivo/ In situ/ In vitro | Assay Type | Comments |
---|---|---|---|
BLESS37 | In situ | Maps un-joined broken ends with sequence-specific adapter | Unbiased; high background; narrow time-window (only maps un-joined ends) |
ChIP-seq18,34,35 | In vivo | Pulls down proteins specifically binding to broken ends or processed ends | Highly depends on the quality of antibody; narrow time-window (only maps un-joined ends); low resolution |
Digenome-seq44 | In vitro | Cleavage of genomic DNA followed by standard whole genome sequencing | Requires in vivo cleavage confirmation; high skill requirement for bioinformatic analysis |
DSB-seq36 | In vitro | Maps un-joined broken ends with biotinylated adapter | Unbiased; high background; narrow time-window (only maps un-joined ends) |
GUIDE-seq27 | In vivo | Randomly incorporates sequence-specific dsDNA fragment into DSB sites | Unbiased; currently limited use for blunt-ended DSBs |
HTGTS11 | In vivo | Maps translocations with induced DSBs | Relatively higher cost and lower sensitivity compared to LAM-HTGTS |
IDLV28,45 | In vivo | Randomly incorporates integrase-deficient viral DNA into DSB sites | Low detection frequency; requires high skill; high cost |
LAM-HTGTS6,8-10 | In vivo | Maps translocations with induced or highly recurrent DSBs | Higher sensitivity on the break-site chromosome; not applicable to limited material |
TC-seq33 | In vivo | Maps translocations with induced DSBs | Does not resolve junction structures; relatively higher cost and lower sensitivity compared to LAM-HTGTS |
Whole genome sequencing (WGS)46 | In vivo | Deep genome sequencing | Covers all types of mutations; expensive; high skill requirement for bioinformatic analysis |
Due to space limitations, only typical methods and references were cited here.